Biomarin Pharmaceutical Inc
XMUN:BM8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biomarin Pharmaceutical Inc
XMUN:BM8
|
US |
|
T
|
Takeda Pharmaceutical Co Ltd
XBER:TKD
|
JP |
|
E
|
EVO Payments Inc
F:E19
|
US |
|
Parker-Hannifin Corp
NYSE:PH
|
US |
|
X
|
X Fab Silicon Foundries EV
F:XFB
|
BE |
|
UDR Inc
NYSE:UDR
|
US |
|
Monolithic Power Systems Inc
NASDAQ:MPWR
|
US |
|
Poste Italiane SpA
OTC:PITAF
|
IT |
Intrinsic Value
The intrinsic value for
Biomarin Pharmaceutical Inc (BM8) under the Base Case is hidden
EUR.
Compared with the current market price of 46.605 EUR, the stock appears hidden
.
BM8 looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if BM8 is one of them.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Biomarin Pharmaceutical Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Biomarin Pharmaceutical Inc
Earnings Waterfall
Biomarin Pharmaceutical Inc
The intrinsic value for
Biomarin Pharmaceutical Inc (BM8) under the Base Case is hidden EUR.
Compared with the current market price of 46.605 EUR, the stock appears hidden.